Pretargeting methods and compounds

Details Pretargeting methods and compounds Pretargeting methods and compounds

1993-11-22

2000-02-08

Cunningham, Thomas M.

Organic compounds -- part of the class 532-570 series

Organic compounds

Unsubstituted hydrocarbyl chain between the ring and the -c-...

5483041, 536 111, C07D25702

Patent

active

060229667

ABSTRACT:
Methods, compounds, compositions and kits that relate to pretargeted delivery of diagnostic and therapeutic agents are disclosed. In particular, methods for radiometal labeling of biotin, as well as related compounds, are described. Articles of manufacture useful in pretargeting methods are also discussed.

REFERENCES:
patent: 4639365 (1987-01-01), Sherry
patent: 4647447 (1987-03-01), Gries et al.
patent: 4687667 (1987-08-01), Meares et al.
patent: 4863713 (1989-09-01), Goodwin et al.
patent: 4923985 (1990-05-01), Gansow et al.
patent: 5141966 (1992-08-01), Porath
patent: 5246692 (1993-09-01), Gansow et al.
patent: 5256395 (1993-10-01), Barbet et al.
patent: 5326778 (1994-07-01), Rosebrough
Sheldon et al., Appl. Radiat. Isot., vol. 43, No. 11, pp. 1399-1402, 1992, "Targeting of [.sup.111 In]Biocytin to Cultured Ovarian Adenocarcinoma Cells Using Covalent Monoclonal Antibody-Streptavidin Conjugates."
Goodwin, J. Nucl. Med., vol. 33, No. 10, pp. 1816-1818, 1992, "New Methods for Localizing Infection: A role for Avidin-Biotin?".
Goodwin, et al., J. Nucl. Med., vol. 33, No. 11, pp. 2006-2013, 1992, "Pretargeted Immunoscintigraphy: Effect of Hapten Valency on Murine Tumor Uptake."
McMurry et al., Bioconjugate Chem., vol. 3, No. 2, pp. 108-117, 1992, "Convenient Synthesis of Bifunctional Tetraaza Macrocyles."
Renn and Meares, Bioconjugate Chem., vol. 3, No. 6, pp. 563-569, 1992, "Large-Scale Synthesis of the Bifunctional Chelating Agent 2-(p-Nitrobenzyl)-1,4,7,10-tetraazacyclododecane-N,N',N",N'"-tetraacetic Acid, and the Determination of Its Enatiomeric Purity by Chiral Chromatography."
Koch and Macke, Angew. Chem. Intl. Ed. Engl., vol. 31, No. 11, pp. 1507-1509, 1992, ".sup.99m Tc Labeled Biotin Conjugate in a Tumor "Pretargeting" Approach with Monoclonal antibodies."
Wu et al., Nucl. Med. Biol. Int. J. Radiat. Appl. Instrum. Part B, vol. 19, No. 2, pp. 239-244, 1992, "Investigations of N-Linked Macrocyles for .sup.111 In and .sup.90 Y Labeling of Proteins."
Goodwin et al., J. Nucl. Med., p. 880, 1992, Abstract No. 232, "Pharmacokinetics of Biotin-Chelate Conjugates for Pretargeted Avidin-Biotin Immunoscintigraphy."
Dischino et al., Inorg. Chem., vol. 30, pp. 1265-1269, 1992, "Synthesis of Nonionic Gadolinium Chelates Useful as Contrast Agents for Magnetic Resonance Imaging."
Sieving et al., Bioconjugate Chem., vol. 1, pp. 65-71, 1990, Preparation and Characterization of Paramagnetic Polychelates and Their Protein Conjugates.
Parker et al., Pure & Appl. Chem., vol. 61, No. 9, pp. 1637-1641, 1989, "Implementation of macrocyclic conjugated antibodies for tumour-targeting. "
Riesen et al., J. Chem. Soc., Chem. Commun., pp. 460-462, 1989, "Synthesis and X-Ray Structural Characterization of Seven Co-ordinate Macrocyclic In.sup.3+ Complexes with Relevance to Radiopharmaceutical Applications."
Moi and Meares, J. Am. Chem. Soc., vol. 110, pp. 6267-6269, 1988, "The Peptide Way to Macrocyclic Bifunctional Chelating Agents: Synthesis of 2-(p-Nitrobenzyl)-1,4,7,10-tetraazacyclododecane-N,N',N",N'"-tetraacetic Acid and Study of Its Yttrium (III) Complex."
Kasprzyk and Wilkins, Inorg. Chem., vol. 21, pp. 3349-3352, 1982, "Kinetics of Interaction of Metal Ions with Two Tetraaza Tetraacetate Macrocycles."
International Search Report for PCT Patent Application No. PCT/US93/05406.
Green, Biochem. J., 89:585, 1963, "The Use of [.sup.14 C]Biotin for Kinetic Studies and for Assay."
Kalofonos et al., J. Nucl. Med., vol. 31, No. 11, pp. 1791-1796, 1990, "Imaging of Tumor in Patients with Indium-111-Labeled Biotin and Streptavidin-Conjugated Antibodies: Preliminary Communication."
Hnatowich et al., J. Nucl. Med., vol. 28, No. 8, pp. 1294-1302, 1987, "Investigations of Avidin and Biotin for Imaging Applications."
Paganelli et al., Int. J. Cancer, 45:1184-1189, 1990, "Intraperitoneal Radio-Localization of Tumors Pre-Targeted by Biotinylated Monoclonal Antibodies."
Paganelli et al., Nuclear Medicine Communications, 12:211-234, 1991, "Monoclonal antibody pretargeting techniques for tumour localization: the avidin-biotin system."
Goodwin/Hnatowich, J. Nucl. Med., vol. 32, No. 4, pp. 750-751, 1991, Letter to the Editor/Reply.
Rosebrough, J. Nucl. Med., p. 880, 1992, Abstract No. 235, "Plasma Stability and Pharmacokinetics of Radio-Labeled Deferoxamine-Biotin Derivatives."
Virzi et al., J. Nucl. Med., p. 920, 1992, Abstract No. 403, "The Preparation and Evaluation of 12 Biotin Derivatives Labeled with Tc-99M."
Rosario et al., J. Nucl. Med., vol. 32, No. 5, p. 993, 1991, Abstract No. 356, "Bolton-Hunter and Biotin Derivatized Polylysine: A New Multi-Valent Peptide Reagent for In Vivo Pre-Targeting with Streptavidin Conjugates."
Rosebrough, J. Pharmacol. Exp. Ther., 1993, 265(1):408.

Affiliated with

Also associated with

Rating

Pretargeting methods and compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pretargeting methods and compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pretargeting methods and compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1682263